Colgate-Palmolive
CL stock analysis · Consumer Staples · Household Products
As of · fund-implied per-share value
Fund holding value ÷ shares held. Not a live quote; not adjusted for later stock splits.
View SEC fund filing ↗Price × SEC outstanding shares. Shares measured 2026-06-30. Approximate; share and price dates can differ.
View share-count filing ↗DCF value
Equity cash-flow scenario · SEC outstanding shares at 2026-06-30 · -24.5% versus input cap
How this is calculated ↗Reverse DCF
Annual basis · read assumptions below
How this is calculated ↗Relative valuation
26 sector peers · median 23.7×
How this is calculated ↗Historical multiples
7 annual observations · snapshot P/E 34.3× · 11.6% versus history
How this is calculated ↗Free cash flow yield
Annual basis · read assumptions below
How this is calculated ↗ROIC / quality
Normalized tax · financing-capital proxy · short-term borrowing coverage incomplete
How this is calculated ↗Value composite
Annual basis · read assumptions below
How this is calculated ↗12–1 price momentum
Split and corporate-action verification is incomplete for these fund observations. Verified adjusted endpoints are required for 12–1 momentum.
How this is calculated ↗Asset growth
Annual basis · read assumptions below
How this is calculated ↗Net payout yield
Requires reported dividends, repurchases and issuance; missing values are not zero.
How this is calculated ↗Accrual quality
Annual basis · read assumptions below
How this is calculated ↗Fundamental momentum
Annual basis · read assumptions below
How this is calculated ↗Follow the cash
ANNUAL · USDOperating cash flow and reinvestment over time
Annual USD. Negative bars use a compressed lower scale. Hover or inspect the financial history table for exact values.
Make the assumptions yours
How sensitive is the valuation?
| Return / Growth | 3.0% | 5.0% | 7.0% |
|---|---|---|---|
| 8.0% | $86.84 | $94.76 | $103.26 |
| 10.0% | $63.64 | $69.24 | $75.25 |
| 12.0% | $50.21 | $54.48 | $59.06 |
Annual financial history
Open SEC filings ↗| Fiscal year-end | Revenue | Net income | Operating cash flow | Capital expenditure | Assets |
|---|---|---|---|---|---|
| 2025-12-31 | 20.4B | 2.3B | 4.2B | 564M | 16.3B |
| 2024-12-31 | 20.1B | 3B | 4.1B | 561M | 16B |
| 2023-12-31 | 19.5B | 2.5B | 3.7B | 705M | 16.4B |
| 2022-12-31 | 18B | 2B | 2.6B | 696M | 15.7B |
| 2021-12-31 | 17.4B | 2.3B | 3.3B | 567M | 15B |
| 2020-12-31 | 16.5B | 2.9B | 3.7B | 409M | 15.9B |
| 2019-12-31 | 15.7B | 2.5B | 3.1B | 335M | 15B |
| 2018-12-31 | 15.5B | 2.6B | 3.1B | 436M | 12.2B |
USD, abbreviated. Restated annual history; not a point-in-time backtest. Missing values appear as dashes.
Trace the inputs
MODEL ANNUAL PERIOD| Input | Value | SEC tag / source | Filed |
|---|---|---|---|
| revenue | 20.4B | RevenueFromContractWithCustomerExcludingAssessedTax | 2026-02-23 |
| netIncome | 2.3B | ProfitLoss Explicit consolidated amount, including the portion attributable to noncontrolling interests. | 2026-02-23 |
| Parent/common earnings proxy | 2.1B | NetIncomeLossAvailableToCommonStockholdersBasic | 2026-02-23 |
| cfo | 4.2B | NetCashProvidedByUsedInOperatingActivities | 2026-02-23 |
| capex | 564M | PaymentsToAcquireProductiveAssets | 2026-02-23 |
| operatingIncome | 3.3B | OperatingIncomeLoss | 2026-02-23 |
| assets | 16.3B | Assets | 2026-02-23 |
| equity | 365M | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Explicit consolidated amount, including the portion attributable to noncontrolling interests. | 2026-02-23 |
| Parent book equity proxy | 54M | StockholdersEquity | 2026-02-23 |
| debt | 8B | LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities | 2026-02-23 |
| shortDebt | — | Not reported under a supported tag | — |
| cash | 1.3B | CashAndCashEquivalentsAtCarryingValue | 2026-02-23 |
| shares | 811.1M | WeightedAverageNumberOfDilutedSharesOutstanding | 2026-02-23 |
| dividends | — | Not reported under a supported tag | — |
| buybacks | 1.2B | PaymentsForRepurchaseOfCommonStock | 2026-02-23 |
| issuance | 101M | Reviewed manual correction Bounded FY2025-12-31 consolidated financing-statement extraction. Proceeds from exercise of stock options: 101000000 USD [us-gaap:ProceedsFromStockOptionsExercised]. All 7 financing lines reconcile exactly to reported financing cash flow -3256000000 USD. Cash inflows from common shares, employee plans and option exercises are summed once as displayed on the statement; noncash compensation, withholding payments, preferred and noncontrolling interests are excluded. This review applies only to this issuer and fiscal period. Source limitation: the statement also aggregates other financing cash flows (net 132000000 USD). Their common-equity portion is not separately disclosed here. Issuance is the sum of separately reported common cash-issuance lines, not an independently verified gross total; additional equity flows may be inside those aggregates. | 2026-02-23 |